CAS: 1246960-27-9 - 2-Piperazinone, 4-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-3-[(1,1-dimethylethoxy)methyl]-, hydrochloride (1:1), (3R)-
Formula:C19H26F3N3O3·ClH
InChI:InChI=1S/C19H26F3N3O3.ClH/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20;/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27);1H/t12-,16-;/m1./s1
InChI key:InChIKey=QHQXWMKKQNSBTC-VQZRABBESA-N
SMILES:Cl.O=C1NCCN(C(=O)CC(N)CC2=CC(F)=C(F)C=C2F)C1COC(C)(C)C
- Synonyms:
- 2-Piperazinone, 4-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-3-[(1,1-dimethylethoxy)methyl]-, hydrochloride (1:1), (3R)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Evogliptin HCl REF: TM-T31732CAS: 1246960-27-9 | - - - | 1,418.00 €~2,331.00 € | Tue 25 Feb 25 |
Evogliptin HCl
CAS:1246960-27-9
Evogliptin (DA-1229), a DPP4 inhibitor, enhances insulin sensitivity and delays diabetes onset.
Formula:
C19H27ClF3N3O3
Color and Shape:
Solid
Molecular weight:
437.88
Ref: TM-T31732
25mg | 1,418.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,331.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025